Chris Blyth is a Paediatric Infectious Diseases Specialist and NHMRC Emerging Leadership Fellow. He is director of the Wesfarmers Centre of Vaccines and Infectious Diseases and Professor of Paediatrics. Based at Perth Children’s Hospital, Telethon Kids Institute and University of Western Australia, his focus is treating children with complicated infections and prevention infection through vaccination. His PhD evaluated the effectiveness of influenza immunisation in children, data critical to inform current influenza policies. He previously has served on the Australian Technical Advisory Group on Immunisation.

Dr. Noor Ali is a Fellow of the Royal Australian and New Zealand College of Ophthalmologists.
She graduated with her medical degree from the University of Auckland, New Zealand in 2010. She completed her Ophthalmology training in New Zealand. She undertook subspecialty training in Medical Retina and Uveitis at the prestigious Sydney Eye Hospital and Westmead Hospital; and in Glaucoma at the world-renowned Oxford Eye Hospital.
She a member of the Australian and New Zealand Society of Retinal Specialist, the Australian and New Zealand Glaucoma Society, as well as the Uveitis Special Interest Group.
Dr Ali is an experienced and precise cataract surgeon with the ultimate goal of clear, crisp vision. She is highly skilled in managing complex cataracts with co-existing glaucoma or ocular inflammation.
In addition to mastering the gold standard glaucoma surgeries such as trabeculectomy and tube implants, she worked at the Imperial College Trust Western Eye Hospital in London and learned the latest techniques in minimally invasive glaucoma surgery or MIGS that can be combined with routine cataract surgery to provide her patients with an opportunity to receive the latest in technological advancements.

Dr. Al-Aly a physician-scientist; he directs the Clinical Epidemiology Center and serves as the Chief of Research and Development Service at the VA Saint Louis Health Care System. He is a senior clinical epidemiologist at Washington University in Saint Louis. He has several research interests including pharmacoepidemiology, environmental epidemiology, global health, and most recently short- and long-term effects of COVID-19 on health outcomes. He led work which provided systematic characterization of the post-acute sequelae of SARS-CoV-2 infection (also called Long Covid) and subsequently characterization of the increased risks of cardiovascular disease, neurologic disorders, diabetes, dyslipidemia, kidney disease, and gastrointestinal disorders following SARS-CoV-2 infection. His laboratory was the first to produce evidence characterizing the effects of vaccines on Long Covid, the health consequences of repeated infections with SARS-CoV-2, and the effect of antivirals on the short- and long-term outcomes of SARS-CoV-2 infection. Dr. Al-Aly co-chaired the U.S. Biden-Harris Administration committee that developed the National Research Action Plan for Long Covid. He serves on the US Government Interagency Long Covid Coordination Council. He advised the Chief Science Advisor of Canada (Mona Nemer – Government of Justin Trudeau) on Long Covid strategy. He currently serves on a consensus committee at the U.S. National Academy of Sciences, Engineering, and Medicine looking at the long-term health effects stemming from COVID-19 and their implications for the U.S. Social Security Administration. He is also a member of the White House Cancer Moonshot Task Force for data and innovation. Dr. Al-Aly’s work is published in prestigious medical journals including Nature, Nature Medicine, the New England Journal of Medicine, the British Medical Journal, the Journal of the American Medical Association, the Lancet and several others. According to Google Scholar, his work has been cited more than 100,000 times. His work is frequently featured in major national and international media outlets including New York Times, Wall Street Journal, Washington Post, LA Times, NPR, BBC, CNN, the Guardian, Bloomberg, The New Yorker, the Atlantic, Rolling Stones, Scientific American, Science Magazine, Nature Magazine, and several others. Several of his studies on Long COVID have generated exceptionally high public and media engagement, ranking in the top 10 of more than 23 million research papers ever tracked by Altmetric, a firm that monitors public engagement in academic research. Dr. Al-Aly serves on multiple national and international committees and boards, and on multiple editorial boards and serves as Associate Editor of the Journal of the American Society of Nephrology – the flagship journal of the American Society of Nephrology. Profile: https://outlook.wustl.edu/real-world-reflections/

Dr Becky Freeman is an Associate Professor at the School of Public Health, University of Sydney. With over twenty years of experience working in the tobacco control field she is well versed in program and policy best practice. She is an established authority on the potential of the Internet to circumvent tobacco advertising bans and has pioneered research methods in tracking and analysing online social media content. Her primary research interests include tobacco control and how online and social media influence public health.

Jasmine Lee is a pharmacist, and PhD candidate at the University of Sydney.

Dr Fiona Foo is a General Clinical and Interventional Cardiologist. As one of <20 female Interventional Cardiologists in Australia, she is one of the first South East Asian Female to have qualified as an Interventional Cardiologist in Australia. At her clinics, she is able to provide the full range of cardiac services. She has interests in Interventional cardiology and has extensive experience in performing Coronary Angiography, Angioplasty and Stents. She also has interests in Women and Heart Disease; Sports Cardiology; Climate Change and Cardiovascular Disease; and Preoperative Cardiac assessment of patients prior to Non cardiac surgery. She promotes an Active and Healthy Lifestyle to her patients. She is also passionate about International probono aid work, particularly in Fiji and Nepal.

Dr. Joanna Fong-Isariyawongse is an Associate Professor of Neurology at the University of Pittsburgh, with a strong emphasis on Sleep Medicine and sleep health advocacy. She possesses extensive knowledge and clinical expertise in sleep medicine, adeptly managing conditions such as sleep apnea, insomnia, and circadian rhythmic sleep disorders. Her dedication to sleep health advocacy is a cornerstone of her career. Dr. Fong-Isariyawongse’s advocacy extends beyond the medical sphere, targeting both the healthcare community and the wider public, with a particular focus on children, adolescents, first responders, and athletes at both student and professional levels. Her mission is to enhance understanding and awareness of the pivotal role of sleep in maintaining health, cognitive function, emotional stability, and life quality across all populations. Alongside her focus on sleep medicine, Dr. Fong-Isariyawongse also specializes in Epilepsy. Her expertise extends to the medical management of patients with epilepsy, including those seeking surgical evaluation for medically refractory epilepsy. She is an expert in critical care EEG and has been instrumental in overseeing the continuous critical care EEG monitoring service across multiple hospitals within the University of Pittsburgh Medical Center (UPMC) system. Her exceptional patient care was recognized when she received UPMC’s Excellence in Patient Experience Award in 2020, a prestigious accolade awarded to only 48 out of 7,600 physicians and advanced practice providers. Furthermore, her outstanding contributions to the field have been acknowledged by Pittsburgh Magazine, which has named her a Best Doctor annually since 2019. Education & Training: • Fellow, Cleveland Clinic – Cleveland, Ohio, Sleep Medicine Fellowship • Fellow, Cleveland Clinic – Cleveland, Ohio, Epilepsy Fellowship • Resident, Cleveland Clinic – Cleveland, Ohio, Neurology • Resident, Cleveland Clinic – Cleveland, Ohio, Preliminary Internal Medicine • M.D., The Ohio State University College of Medicine – Columbus, Ohio, Medicine • B.A., University of California, Berkeley – Berkeley, CA, Biochemistry & Molecular Cell Biology